111 related articles for article (PubMed ID: 9218926)
1. Cytotoxic activity of cyclosporin A and [3-keto-Bmt1]-[Val2]-cyclosporin (SDZ PSC 833) on tumour cells from patients with haematological malignancies.
Martinsson P; Nygren P; Fridborg H; Nilsson K; Kristensen J; Larsson R
Eur J Clin Pharmacol; 1997; 52(3):199-203. PubMed ID: 9218926
[TBL] [Abstract][Full Text] [Related]
2. Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
Fridborg H; Jonsson B; Nygren P; Csoka K; Nilsson K; Oberg G; Kristensen J; Bergh J; Tholander B; Olsen L
Br J Cancer; 1994 Jul; 70(1):11-7. PubMed ID: 8018519
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein.
Archinal-Mattheis A; Rzepka RW; Watanabe T; Kokubu N; Itoh Y; Combates NJ; Bair KW; Cohen D
Oncol Res; 1995; 7(12):603-10. PubMed ID: 8704277
[TBL] [Abstract][Full Text] [Related]
4. Effect of SDZ PSC 833 ([3'-keto-Bmt1]-[Val2]-cyclosporin) on serum protein binding and distribution to blood cells of doxorubicin, vincristine and etoposide in vitro.
Watanabe T; Iwasaki M; Todaka T; Morikawa H; Ohtawa M
Anticancer Drugs; 1997 Apr; 8(4):400-4. PubMed ID: 9180396
[TBL] [Abstract][Full Text] [Related]
5. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia.
Grey MR; Burgess R; Fisher A; Yin JA
Leuk Res; 1999 Jan; 23(1):29-35. PubMed ID: 9933132
[TBL] [Abstract][Full Text] [Related]
6. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
Grey M; Borg AG; Wood P; Burgess R; Fisher A; Yin JA
Leuk Res; 1997 Sep; 21(9):867-74. PubMed ID: 9393602
[TBL] [Abstract][Full Text] [Related]
7. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
Jiang XR; Kelsey SM; Wu YL; Newland AC
Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity of calcein acetoxymethyl ester (Calcein/AM) on primary cultures of human haematological and solid tumours.
Jonsson B; Liminga G; Csoka K; Fridborg H; Dhar S; Nygren P; Larsson R
Eur J Cancer; 1996 May; 32A(5):883-7. PubMed ID: 9081371
[TBL] [Abstract][Full Text] [Related]
9. Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
Nygren P; Larsson R
Int J Cancer; 1991 Jun; 48(4):598-604. PubMed ID: 2045203
[TBL] [Abstract][Full Text] [Related]
10. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
[TBL] [Abstract][Full Text] [Related]
11. SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma.
Jonsson B; Nilsson K; Nygren P; Larsson R
Anticancer Drugs; 1992 Dec; 3(6):641-6. PubMed ID: 1363199
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor.
Friche E; Jensen PB; Nissen NI
Cancer Chemother Pharmacol; 1992; 30(3):235-7. PubMed ID: 1628375
[TBL] [Abstract][Full Text] [Related]
13. Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin [corrected].
Twentyman PR; Bleehen NM
Eur J Cancer; 1991; 27(12):1639-42. PubMed ID: 1816768
[TBL] [Abstract][Full Text] [Related]
14. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
Jachez B; Loor F
Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
[TBL] [Abstract][Full Text] [Related]
15. Selective cytotoxic activity of cyclosporins against tumor cells from patients with B cell chronic lymphocytic leukemia.
Larsson R; Jonsson B; Csoka K; Kristensen J; Nilsson K; Nygren P
Eur J Pharmacol; 1992 Dec; 228(4):237-40. PubMed ID: 1478273
[TBL] [Abstract][Full Text] [Related]
16. A bioassay for the activity of PSC 833 in human serum for modulation of P-glycoprotein-mediated multidrug resistance.
Uchiyama-Kokubu N; Watanabe T; Nakajima M
Anticancer Drugs; 2000 Aug; 11(7):583-90. PubMed ID: 11036963
[TBL] [Abstract][Full Text] [Related]
17. Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia.
Merlin JL; Guerci AP; Marchal S; Bour C; Colosetti P; Kataki A; Guerci O
Br J Haematol; 1998 Nov; 103(2):480-7. PubMed ID: 9827923
[TBL] [Abstract][Full Text] [Related]
18. [SDZ PSC 833: a novel modulator of MDR].
Covelli A
Tumori; 1997; 83(5 Suppl):S21-4. PubMed ID: 9446255
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells.
Larsson R; Nygren P
Int J Cancer; 1990 Jul; 46(1):67-72. PubMed ID: 2194983
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein.
Watanabe T; Kokubu N; Charnick SB; Naito M; Tsuruo T; Cohen D
Br J Pharmacol; 1997 Sep; 122(2):241-8. PubMed ID: 9313931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
